Spending on pharmaceuticals per capita in Finland was EUR 377 in 2015, a lower level than in most other EU countries. To contain cost, Finland has also used price freezes and cuts. In 2009, reference pricing was introduced and reimbursement since then is based on the reference price, that is, the price of the cheapest substitutable product plus a small premium. Coverage decisions are reviewed based on the reassessment.